semaglutide and heart disease breakthrough: new hope for health in the fight against obesity – CheqUp Semaglutide may reduce heart events

No sugar, no calories, and full of flavor

Abstract Introduction: Prader-Willi syndrome (PWS) is the most prevalent cause of syndromic obesity

Across SELECT, FLOW, and SURMOUNT outcome data, cardiovascular and kidney effects appear net positive over multi-year follow-up

Key Takeaways Oregon telehealth law (ORS 677.097) permits fully remote GLP-1 prescribing by Oregon-licensed physicians without requiring in-person visits

Schmitz Medical Weight Management Our comprehensive, physician-supervised weight management program combines medical expertise, personalized nutrition, and lifestyle support to achieve safe, lasting results through a comprehensive approach that goes beyond quick-fix solutions

Lipo C works primarily through hepatic and systemic support rather than appetite suppression